Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 5/2019

03.01.2019 | Original Article

Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo

verfasst von: Feng Li, Jarrett D. Cain, Joyce Tombran-Tink, Christopher Niyibizi

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Mutations in Serpinf1 gene which encodes pigment epithelium-derived factor (PEDF) lead to osteogenesis imperfecta type VI whose hallmark is defective matrix mineralization. We reported previously that PEDF reduced expression and synthesis of Sost/Sclerostin as well as other osteocytes genes encoding proteins that regulate matrix mineralization [1]. To determine whether PEDF had an effect on osteocyte gene expression in bone, we used bone explant cultures. First, osteocytes were isolated from surgical waste of bone fragments obtained from patients undergoing elective foot surgeries under approved IRB protocol by Penn State College of Medicine IRB committee. Primary osteocytes treated with PEDF reduced expression and synthesis of Sost/Sclerostin and matrix phosphoglycoprotein (MEPE) as well as dentin matrix protein (DMP-1). On the whole, PEDF reduced osteocyte protein synthesis by 50% and by 75% on mRNA levels. For bone explants, following collagenase digestion, bone fragments were incubated in alpha-MEM supplemented with 250 ng/ml of PEDF or BSA. After 7 days of incubation in a medium supplemented with PEDF, analysis of mRNA by PCR and protein by western blotting of encoded osteocyte proteins showed reduced Sclerostin synthesis by 39% and MEPE by 27% when compared to fragments incubated in medium supplemented with BSA. mRNA expression levels of osteocytes in bone fragments treated with PEDF were reduced by 50% for both SOST and MEPE when compared to BSA-treated bone fragments. Taken together, the data indicate that PEDF has an effect on osteocyte gene expression in bone and encourage further studies to examine effect of PEDF on bone formation indices in animal models and its effect on osteocyte gene expression in vivo following PEDF administration.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Li F, Song N, Tombran-Tink J, Niyibizi C (2015) Pigment epithelium derived factor suppresses expression of Sost/sclerostin by osteocytes: implication for its role in bone matrix mineralization. J Cell Physiol 24:1651–1661 Li F, Song N, Tombran-Tink J, Niyibizi C (2015) Pigment epithelium derived factor suppresses expression of Sost/sclerostin by osteocytes: implication for its role in bone matrix mineralization. J Cell Physiol 24:1651–1661
2.
Zurück zum Zitat Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245–248CrossRefPubMed Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245–248CrossRefPubMed
3.
Zurück zum Zitat Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53:411–414CrossRefPubMed Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53:411–414CrossRefPubMed
4.
Zurück zum Zitat Steele FR, Chader GJ, Johnson LV, Tombran-Tink J (1993) Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A. 90:1526–1530CrossRefPubMedPubMedCentral Steele FR, Chader GJ, Johnson LV, Tombran-Tink J (1993) Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A. 90:1526–1530CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ho TC, Chen SL, Shih SC, Wu JY, Han WH, Cheng HC, Yang SL, Tsao YP (2010) Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells. Am J Pathol 177:1798–1811CrossRefPubMedPubMedCentral Ho TC, Chen SL, Shih SC, Wu JY, Han WH, Cheng HC, Yang SL, Tsao YP (2010) Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells. Am J Pathol 177:1798–1811CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604–3613CrossRefPubMed Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604–3613CrossRefPubMed
8.
Zurück zum Zitat Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362–371CrossRefPubMedPubMedCentral Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, de Vries P, Wirth B, Schoenau E, Wollnik B, Veltman JA, Hoischen A, Netzer C (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362–371CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798–2803CrossRefPubMedPubMedCentral Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, White L, Miki R, Cohn DH, Crawford S, Travers R, Glorieux FH, Lee B (2011) Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res 26:2798–2803CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Venturi G, Gandini A, Monti E, Dalle Carbonare L, Corradi M, Vincenzi M, Valenti MT, Valli M, Pelilli E, Boner A, Mottes M, Antoniazzi F (2012) Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res 27:723–728CrossRefPubMed Venturi G, Gandini A, Monti E, Dalle Carbonare L, Corradi M, Vincenzi M, Valenti MT, Valli M, Pelilli E, Boner A, Mottes M, Antoniazzi F (2012) Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res 27:723–728CrossRefPubMed
11.
Zurück zum Zitat Li F, Song N, Tombran-Tink J, Niyibizi C (2013) Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells 31:2714–2723CrossRefPubMed Li F, Song N, Tombran-Tink J, Niyibizi C (2013) Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells. Stem Cells 31:2714–2723CrossRefPubMed
12.
Zurück zum Zitat Gattu AK, Swenson ES, Iwakiri Y, Samuel VT, Troiano N, Berry R, Church CD, Rodeheffer MS, Carpenter TO, Chung C (2013) Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J 27:4384–4394CrossRefPubMedPubMedCentral Gattu AK, Swenson ES, Iwakiri Y, Samuel VT, Troiano N, Berry R, Church CD, Rodeheffer MS, Carpenter TO, Chung C (2013) Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J 27:4384–4394CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Belinsky GS, Sreekumar B, Andrejecsk JW, Saltzman WM, Gong J, Herzog RI, Lin S, Horsley V, Carpenter TO, Chung C (2016) Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade. FASEB J 30:2837–2848CrossRefPubMedPubMedCentral Belinsky GS, Sreekumar B, Andrejecsk JW, Saltzman WM, Gong J, Herzog RI, Lin S, Horsley V, Carpenter TO, Chung C (2016) Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade. FASEB J 30:2837–2848CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sekiya H, Mikuni-Takagaki Y, Kondoh T, Seto K (1999) Synergistic effect of PTH on the mechanical responses of human alveolar osteocytes. Biochem Biophys Res Commun 264:719–723CrossRefPubMed Sekiya H, Mikuni-Takagaki Y, Kondoh T, Seto K (1999) Synergistic effect of PTH on the mechanical responses of human alveolar osteocytes. Biochem Biophys Res Commun 264:719–723CrossRefPubMed
15.
Zurück zum Zitat Gu G, Nars M, Hentunen TA, Metsikko K, Vaananen HK (2006) Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res 323:263–271CrossRefPubMed Gu G, Nars M, Hentunen TA, Metsikko K, Vaananen HK (2006) Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res 323:263–271CrossRefPubMed
16.
Zurück zum Zitat Stern AR, Stern MM, Van Dyke ME, Jahn K, Prideaux M, Bonewald LF (2012) Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 52:361–373PubMedPubMedCentral Stern AR, Stern MM, Van Dyke ME, Jahn K, Prideaux M, Bonewald LF (2012) Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 52:361–373PubMedPubMedCentral
17.
Zurück zum Zitat Abubakar AA, Noordin MM, Azmi TI, Kaka U, Loqman MY (2016) The use of rats and mice as animal models in ex vivo bone growth and development studies. Bone Joint Res 5:610–618CrossRefPubMed Abubakar AA, Noordin MM, Azmi TI, Kaka U, Loqman MY (2016) The use of rats and mice as animal models in ex vivo bone growth and development studies. Bone Joint Res 5:610–618CrossRefPubMed
18.
Zurück zum Zitat Okubo N, Minami Y, Fujiwara H, Umemura Y, Tsuchiya Y, Shirai T, Oda R, Inokawa H, Kubo T, Yagita K (2013) Prolonged bioluminescence monitoring in mouse ex vivo bone culture revealed persistent circadian rhythms in articular cartilages and growth plates. PLoS One 8:e78306CrossRefPubMedPubMedCentral Okubo N, Minami Y, Fujiwara H, Umemura Y, Tsuchiya Y, Shirai T, Oda R, Inokawa H, Kubo T, Yagita K (2013) Prolonged bioluminescence monitoring in mouse ex vivo bone culture revealed persistent circadian rhythms in articular cartilages and growth plates. PLoS One 8:e78306CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Chan ME, Lu XL, Huo B, Baik AD, Chiang V, Guldberg RE, Lu HH, Guo XE (2009) A trabecular bone explant model of osteocyte-osteoblast co-culture for bone mechanobiology. Cell Mol Bioeng 2:405–415CrossRefPubMedPubMedCentral Chan ME, Lu XL, Huo B, Baik AD, Chiang V, Guldberg RE, Lu HH, Guo XE (2009) A trabecular bone explant model of osteocyte-osteoblast co-culture for bone mechanobiology. Cell Mol Bioeng 2:405–415CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Marino S, Staines KA, Brown G, Howard-Jones RA, Adamczyk M (2016) Models of ex vivo explant cultures: applications in bone research. BoneKEy Rep 5:818CrossRefPubMedPubMedCentral Marino S, Staines KA, Brown G, Howard-Jones RA, Adamczyk M (2016) Models of ex vivo explant cultures: applications in bone research. BoneKEy Rep 5:818CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Li F, Cain J, Tombran-Tink J, Niyibizi C (2018) Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/Gsk-3beta/beta-catenin signaling. Biochem Biophy Acta Mol Basis Dis 1864:3449–3458CrossRef Li F, Cain J, Tombran-Tink J, Niyibizi C (2018) Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/Gsk-3beta/beta-catenin signaling. Biochem Biophy Acta Mol Basis Dis 1864:3449–3458CrossRef
22.
Zurück zum Zitat Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR, Zelenchuk L, Evdokiou A, Findlay DM (2011) Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26:1425–1436CrossRefPubMedPubMedCentral Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR, Zelenchuk L, Evdokiou A, Findlay DM (2011) Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 26:1425–1436CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22:6267–6276CrossRefPubMedPubMedCentral Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, Shpektor D, Jonas M, Kovacevich BR, Staehling-Hampton K, Appleby M, Brunkow ME, Latham JA (2003) Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22:6267–6276CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Paszty C, Turner CH, Robinson MK (2010) Sclerostin: a gem from the genome leads to bone-building antibodies. J Bone Miner Res 25:1897–1904CrossRefPubMed Paszty C, Turner CH, Robinson MK (2010) Sclerostin: a gem from the genome leads to bone-building antibodies. J Bone Miner Res 25:1897–1904CrossRefPubMed
25.
Zurück zum Zitat Tian X, Jee WS, Li X, Paszty C, Ke HZ (2011) Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Bone 48:197–201CrossRefPubMed Tian X, Jee WS, Li X, Paszty C, Ke HZ (2011) Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model. Bone 48:197–201CrossRefPubMed
26.
Zurück zum Zitat Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Li Y, Feng G, Gao X, He L (2009) Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res 24:1651–1661CrossRefPubMed Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Li Y, Feng G, Gao X, He L (2009) Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res 24:1651–1661CrossRefPubMed
27.
Zurück zum Zitat Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (2008) MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23:1638–1649CrossRefPubMed Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (2008) MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 23:1638–1649CrossRefPubMed
28.
Zurück zum Zitat Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (2008) Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 149:1757–1772CrossRefPubMed Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (2008) Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP. Endocrinology 149:1757–1772CrossRefPubMed
29.
Zurück zum Zitat David V, Martin A, Hedge AM, Rowe PS (2009) Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 150:4012–4023CrossRefPubMedPubMedCentral David V, Martin A, Hedge AM, Rowe PS (2009) Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator. Endocrinology 150:4012–4023CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Lu P, Zhang YQ, Zhang H, Li YF, Wang XY, Xu H, Liu ZW, Li L, Dong HY, Zhang ZM (2016) Pigment epithelium-derived factor (PEDF) improves ischemic cardiac functional reserve through decreasing hypoxic cardiomyocyte contractility through PEDF receptor (PEDF-R). J Am Heart Assoc 5:e003179PubMedPubMedCentral Lu P, Zhang YQ, Zhang H, Li YF, Wang XY, Xu H, Liu ZW, Li L, Dong HY, Zhang ZM (2016) Pigment epithelium-derived factor (PEDF) improves ischemic cardiac functional reserve through decreasing hypoxic cardiomyocyte contractility through PEDF receptor (PEDF-R). J Am Heart Assoc 5:e003179PubMedPubMedCentral
31.
Zurück zum Zitat Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998–2007CrossRefPubMed Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, Simmons HA, Crawford DT, Chidsey-Frink KL, Ke HZ, McNeish JD, Brown TA (2003) Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 278:1998–2007CrossRefPubMed
32.
Zurück zum Zitat Staines KA, Pollard AS, McGonnell IM, Farquharson C, Pitsillides AA (2013) Cartilage to bone transitions in health and disease. J Endocrinol 219:R1–R12CrossRefPubMedPubMedCentral Staines KA, Pollard AS, McGonnell IM, Farquharson C, Pitsillides AA (2013) Cartilage to bone transitions in health and disease. J Endocrinol 219:R1–R12CrossRefPubMedPubMedCentral
Metadaten
Titel
Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo
verfasst von
Feng Li
Jarrett D. Cain
Joyce Tombran-Tink
Christopher Niyibizi
Publikationsdatum
03.01.2019
Verlag
Springer Japan
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 5/2019
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-018-0982-4

Weitere Artikel der Ausgabe 5/2019

Journal of Bone and Mineral Metabolism 5/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.